-
Mashup Score: 8
Alembic’s Ticagrelor Approval: A Strategic Move in the Generic Antiplatelet Market
Source: www.ainvest.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 19Hemorrhage Into the Canal of Gratiolet - 3 day(s) ago
This case report describes a unilateral basal ganglia hemorrhage passing through the anterior commissure within the canal of Gratiolet to the contralateral side.
Source: jamanetwork.comCategories: General Medicine News, NephrologyTweet-
Hemorrhage Into the Canal of Gratiolet https://t.co/5oPujSCHBQ
-
-
Mashup Score: 35US FDA clears first blood test to detect Alzheimer's disease - 4 day(s) ago
The U.S. Food and Drug Administration said on Friday it had cleared Fujirebio Diagnostics’ blood test to diagnose Alzheimer’s disease, making the test the first of its kind to detect the condition.
Source: www.reuters.comCategories: General Medicine News, NephrologyTweet-
US FDA clears first blood test for Alzheimer's detection https://t.co/N6WP2s52Az https://t.co/YUQa1M4kCI
-
-
Mashup Score: 20The fluid mechanics of aspiration thrombectomy - 4 day(s) ago
Large vessel occlusion causing acute ischemic stroke is ideally treated with endovascular clot retrieval, which is increasingly being performed via direct aspiration thrombectomy. Successful aspiration thrombectomy depends on multiple tenets of fluid and solid mechanics, including the application of hydrostatic and hydrodynamic forces to lodged clots. These fundamental concepts predict factors that may increase efficacy in clot removal, and help to explain the differences in performance seen among varying aspiration techniques (remote vs direct), catheters (suction force increases with diameter), and vacuum sources (pump type, whether electrical or manual, should not have an impact on negative pressure). Cyclic aspiration is also predicted to show more substantial clot removal and ingestion than static aspiration due to the dynamic forces it imposes on elastic clots. In this paper we will review the basic scientific principles underlying the fluid mechanics of aspiration thrombectomy a
Source: jnis.bmj.comCategories: General Medicine News, NephrologyTweet-
The fluid mechanics of aspiration thrombectomy https://t.co/MGg5owOlAo https://t.co/GsBx8OOnP3
-
-
Mashup Score: 12Management of carotid artery web: a nationwide survey of vascular neurologists versus neurointerventionalists - 4 day(s) ago
Background Carotid artery web (CW) is an under-recognized cause of cryptogenic stroke, with variability in practice and controversy regarding its optimal management. Due to the lack of society guidelines, it is unclear how neurointerventional radiologists (NIRs) and vascular neurologists approach this condition. Therefore, we conducted a survey to understand practice patterns for the management of CW. Methods A 10-question survey, including demographic data and clinical vignettes, was developed using REDCap (Research Electronic Data Capture) and sent to board-certified vascular neurologists and NIRs. Responses were categorized into binary outcomes (medical therapy vs carotid revascularization). Statistical analyses, including Chi-square, Fisher’s exact, and Kruskal–Wallis, were used for group comparisons. Results Of 1640 participants, 247 completed the survey, with 77% being vascular neurologists and 23% neurointerventionalists. Participants identified cryptogenic stroke (80.1%) and re
Source: jnis.bmj.comCategories: General Medicine News, NephrologyTweet-
Management of carotid artery web: a nationwide survey of vascular neurologists versus neurointerventionalists https://t.co/kzcdhQWYcP
-
-
Mashup Score: 8ACCESS: ACCESS S:VIN April 2025 - 6 day(s) ago
This episode of ACCESS, the official podcast of Stroke: Vascular & Interventional Neurology, provides an overview of the 1st and 2nd issue of 2025. Highlights of the journal with summaries of the latest advances in vascular and interventional neurology by Editor-in-Chief, Dr. Ashutosh Jadhav followed by a discussion with Dr. Lauren Sansing, Dr. Bijoy Menon, Dr. Robert Regenhardt and Dr. Vivek Yedavalli on the ground breaking research discussed at ISC 2025 held in Los Angeles.
Source: accesssvin.libsyn.comCategories: General Medicine News, NephrologyTweet-
This episode of ACCESS, the official podcast of Stroke: Vascular & Interventional Neurology, provides an overview of the 1st and 2nd issue of 2025. @StrokeAHA_ASA @svinsociety @SVINJournal https://t.co/Pm9BAnOwNb https://t.co/RDuCVqnmgz
-
-
Mashup Score: 3Characterization of Research Grant Terminations at the National Institutes of Health - 12 day(s) ago
This study examines the impact of National Institutes of Health grant terminations on the US research enterprise by quantifying the number and funding amount of these terminations and characterizing their award type and institute or center.
Source: jamanetwork.comCategories: General Medicine News, NephrologyTweet-
Characterization of Research Grant Terminations at the National Institutes of Health https://t.co/LTjJ3TBcNt
-
-
Mashup Score: 3Characterization of Research Grant Terminations at the National Institutes of Health - 13 day(s) ago
This study examines the impact of National Institutes of Health grant terminations on the US research enterprise by quantifying the number and funding amount of these terminations and characterizing their award type and institute or center.
Source: jamanetwork.comCategories: General Medicine News, NephrologyTweet-
Characterization of Research Grant Terminations at the National Institutes of Health https://t.co/LTjJ3TBcNt
-
-
Mashup Score: 3Characterization of Research Grant Terminations at the National Institutes of Health - 14 day(s) ago
This study examines the impact of National Institutes of Health grant terminations on the US research enterprise by quantifying the number and funding amount of these terminations and characterizing their award type and institute or center.
Source: jamanetwork.comCategories: General Medicine News, NephrologyTweet-
Characterization of Research Grant Terminations at the National Institutes of Health https://t.co/LTjJ3TBcNt
-
-
Mashup Score: 68Thrombolytic agents, more options, more challenges - 14 day(s) ago
Acute ischaemic stroke (AIS) is a leading cause of disability and mortality worldwide. Intravenous thrombolytic therapy is the cornerstone treatments, aiming to restore blood flow in the occluded cerebral vessels. Alteplase has been the standard thrombolytic agent since 1995. However, the exploration of other available thrombolytic agents such as tenecteplase (TNK), prourokinase and reteplase for easier administration, more effective and safer alternatives has led to the development of new agents. 1 Dozens of trials were performed to compare those to conventional alteplase, especially among specific subgroup patients. We would like to illustrate the pearls and pitfalls in AIS care. A better understanding of these new alternative agents will assist clinicians to adhere to the guidelines and yet know the pros and cons of potential options.
Source: svn.bmj.comCategories: General Medicine News, NephrologyTweet-
Thrombolytic agents, more options, more challenges https://t.co/7zJNlyJF2H https://t.co/NP2QRhvhoZ
-
Alembic’s Ticagrelor Approval: A Strategic Move in the Generic Antiplatelet Market https://t.co/O1TcF1Yu45 https://t.co/hb7Mnlj0UG